Is plasminogen deficiency a thrombotic risk factor? - A study on 23 thrombophilic patients and their family members

Thrombosis and Haemostasis

Volumn 80, Issue 1, 1998, Pages 167-170

  Demarmels Biasiutti, F ^a   Sulzer, I ^a   Stucki, B ^a   Wuillemin, W A ^a   Furlan, M ^a   Lammle B ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; PLASMINOGEN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0031878998     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615157     Document Type: Article

References (26)

1. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: part 1. Thromb Haemost 1996; 76: 651-62.
2. Francis RB Jr. Clinical disorders of fibrinolysis: a critical review. Blut 1989; 9: 1-14.
3. Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: Low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J 1985; 290: 1453-5.
4. Tait RC, Walker ID, Islam SIA, Mitchell R, Davidson JF. Plasminogen levels and putative prevalence of deficiency in 400 blood donors. Br J Haematol 1991; 77 (S 1): 10 (Abstr).
5. Beck KH, Walter-Fincke R, Hach V, Scharrer I. Incidence of protein C deficiency in 132 juvenile thrombosis patients in comparison with other inherited fibrinolysis disorders. Thromb Haemost 1985; 54: 142 (Abstr).
6. Heijboer H, Brandjes DPM. Büller HR, Sturk A, ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep vein thrombosis. N Engl J Med 1990; 323: 1512-6.
7. Hasegawa DK, Tyler BJ, Edson JR. Thrombotic disease in three families with inherited plasminogen deficiency. Blood (S 1) 1982; 60: 213a (Abstr).
8. Aoki N, Moroi M, Sakata Y, Yoshida N, Matsuda M. Abnormal plasminogen. J Clin Invest 1978; 61: 1186-95.
9. Leebeek FWG, Knot EAR, ten Cate JW, Traas DW. Severe thrombotic tendency with a type I plasminogen deficiency. Am J Hematol 1989; 30: 32-5.
10. Girolami A, Marafioti F, Rubertelli M, Cappellato MG. Congenital heterozygous plasminogen deficiency associated with a severe thrombotic tendency. Acta haemat 1986; 75: 54-7.
11. Sartori MT, Patrassi GM, Theodoridis P, Perin A, Pietrogrande F, Girolami A. Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis: a statistical analysis in 20 kindreds. Blood Coag Fibrinol 1994; 5: 889-93.
12. Kazama M, Tahara C, Suzuki Z, Gohchi K, Abe T. Abnormal plasminogen, a case of recurrent thrombosis. Thromb Res 1981; 21: 517-22.
13. Dolan G, Greaves M, Cooper P, Preston FE. Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds. Br J Haematol 1988; 70: 417-421.
14. Hach-Wunderle V, Scharrer I, Lottenberg R. Congenital deficiency of plasminogen and its relationship to venous thrombosis. Thromb Haemost 1988; 59: 277-80.
15. Shigekiyo T, Uno Y, Tomonari A, Satoh K, Hondo H, Ueda S, Saito S. Type I congenital plasminogen deficiency is not a risk factor for thrombosis. Thromb Haemost 1992; 67: 189-92.
16. Tait RC, Walker ID, Conkie JA, Islam IAM, McCall F. Isolated familial plasminogen deficiency may not be a risk factor for thrombosis. Thromb Haemost 1996; 76: 1004-8.
17. Schuster V, Mingers A-M, Seidenspinner S, Nüssgens Z, Pukrop T, Kreth HW. Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. Blood 1997; 90: 958-66.
18. Ploplis VA, Carmeliet P, Vazirzadeh S, Vanvlaenderen I, Moons L, Plow EF, Collen D. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995; 92: 2585-93.
19. Tait RC, Walker ID, Conkie JA, Islam SIAM, Mc Call F, Mitchell R, Davidson JF. Plasminogen levels in healthy volunteers - influence of age, sex, smoking and oral contraceptives. Thromb Haemost 1992; 68: 506-10.
20. Rodeghiero F, Tosetto A. The VITA Project: Population based distributions of protein C, antithrombin III, heparin-cofactor II and plasminogen - relationship with physiological variables and establishment of reference ranges. Thromb Haemost 1996; 76: 226-33.
21. Demarmels Biasiutti F, Lämmle B. Thrombophilieabklärung: Indikation und Durchführung. Ther Umschau 1992; 49: 850-8.
22. Dolan G, Preston FE. Familial plasminogen deficiency and thromboembolism. Fibrinolysis 1988; 2 (S2): 26-34.
23. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
24. Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-4.
25. Dahlbäck B, Hillarp A, Rosen S, Zöller B. Resistance to activated protein C, the FV: Q506 allele, and venous thrombosis. Ann Hematol 1996; 72: 166-76.
26. Züger M, Demarmels Biasiutti F, Furlan M, Mannhalter Ch, Lämmle B. Plasminogen deficiency: An additional risk factor for thrombosis in a family with factor VR506Q mutation? Thromb Haemost 1996; 76: 475-6.